Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control
The recent surge of COVID-19 related to the Omicron variant emergence has thrown a harsh light upon epidemic control in the near future. This should lead the scientific and medical community to question the long-term vaccine strategy for SARS-CoV-2 control. We provide here a critical point of view r...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-09-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/10/9/1555 |
| _version_ | 1797481526040985600 |
|---|---|
| author | Marie Mura Fabrice Simon Vincent Pommier de Santi Frédéric Tangy Jean-Nicolas Tournier |
| author_facet | Marie Mura Fabrice Simon Vincent Pommier de Santi Frédéric Tangy Jean-Nicolas Tournier |
| author_sort | Marie Mura |
| collection | DOAJ |
| description | The recent surge of COVID-19 related to the Omicron variant emergence has thrown a harsh light upon epidemic control in the near future. This should lead the scientific and medical community to question the long-term vaccine strategy for SARS-CoV-2 control. We provide here a critical point of view regarding the virological evolution, epidemiological aspects, and immunological drivers for COVID-19 control, including a vaccination strategy. Overall, we need more innovations in vaccine development to reduce the COVID-19 burden long term. The most adequate answer might be better cooperation between universities, biotech and pharmaceutical companies |
| first_indexed | 2024-03-09T22:15:51Z |
| format | Article |
| id | doaj.art-010f4b62fd684976b701872cf5d8eb8a |
| institution | Directory Open Access Journal |
| issn | 2076-393X |
| language | English |
| last_indexed | 2024-03-09T22:15:51Z |
| publishDate | 2022-09-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Vaccines |
| spelling | doaj.art-010f4b62fd684976b701872cf5d8eb8a2023-11-23T19:23:08ZengMDPI AGVaccines2076-393X2022-09-01109155510.3390/vaccines10091555Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic ControlMarie Mura0Fabrice Simon1Vincent Pommier de Santi2Frédéric Tangy3Jean-Nicolas Tournier4Microbiology and Infectious Diseases Department, Institut de Recherche Biomédicale des Armées (IRBA), 91220 Brétigny sur Orge, FranceDepartment of Infectious Diseases and Tropical Medicine, HIA Laveran, 13384 Marseille, FranceFrench Armed Forces Center for Epidemiology and Public Health (CESPA), 13014 Marseille, FranceInnovative Vaccine Laboratory, Institut Pasteur, 75015 Paris, FranceMicrobiology and Infectious Diseases Department, Institut de Recherche Biomédicale des Armées (IRBA), 91220 Brétigny sur Orge, FranceThe recent surge of COVID-19 related to the Omicron variant emergence has thrown a harsh light upon epidemic control in the near future. This should lead the scientific and medical community to question the long-term vaccine strategy for SARS-CoV-2 control. We provide here a critical point of view regarding the virological evolution, epidemiological aspects, and immunological drivers for COVID-19 control, including a vaccination strategy. Overall, we need more innovations in vaccine development to reduce the COVID-19 burden long term. The most adequate answer might be better cooperation between universities, biotech and pharmaceutical companieshttps://www.mdpi.com/2076-393X/10/9/1555SARS-CoV-2COVID-19vaccinevariantOmicronDelta |
| spellingShingle | Marie Mura Fabrice Simon Vincent Pommier de Santi Frédéric Tangy Jean-Nicolas Tournier Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control Vaccines SARS-CoV-2 COVID-19 vaccine variant Omicron Delta |
| title | Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control |
| title_full | Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control |
| title_fullStr | Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control |
| title_full_unstemmed | Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control |
| title_short | Role and Limits of COVID-19 Vaccines in the Delicate Transition from Pandemic Mitigation to Endemic Control |
| title_sort | role and limits of covid 19 vaccines in the delicate transition from pandemic mitigation to endemic control |
| topic | SARS-CoV-2 COVID-19 vaccine variant Omicron Delta |
| url | https://www.mdpi.com/2076-393X/10/9/1555 |
| work_keys_str_mv | AT mariemura roleandlimitsofcovid19vaccinesinthedelicatetransitionfrompandemicmitigationtoendemiccontrol AT fabricesimon roleandlimitsofcovid19vaccinesinthedelicatetransitionfrompandemicmitigationtoendemiccontrol AT vincentpommierdesanti roleandlimitsofcovid19vaccinesinthedelicatetransitionfrompandemicmitigationtoendemiccontrol AT frederictangy roleandlimitsofcovid19vaccinesinthedelicatetransitionfrompandemicmitigationtoendemiccontrol AT jeannicolastournier roleandlimitsofcovid19vaccinesinthedelicatetransitionfrompandemicmitigationtoendemiccontrol |